中药预防结肠癌的研究进展
Research Progress of Traditional Chinese Medicine in the Prevention of Colorectal Cancer
DOI: 10.12677/tcm.2025.142080, PDF,   
作者: 徐督辉*, 王 威#：天津中医药大学第一附属医院，天津；国家中医针灸临床医学研究中心，天津
关键词: 中药预防；结肠癌；免疫调节；细胞凋亡；耐药机制；Traditional Chinese Medicine Prevention； Colorectal Cancer； Immune Regulation； Cell Apoptosis； Drug Resistance Mechanisms
摘要: 结肠癌(CRC)作为消化系统中常见的恶性肿瘤，其发病率和死亡率持续上升，已成为全球健康的重大挑战之一。结肠癌的高发病率和死亡率促使对其预防的深入研究，对结肠癌的早期预防和干预不仅可以有效降低发病率，也能改善患者的生活质量。中医药以其独特的治疗机制展现出显著的潜力，中药通过抑制结肠癌前期病变、调控细胞生长、促进细胞凋亡、改善机体免疫功能以及逆转耐药性等多重机制，发挥了预防结肠癌的作用。此外，研究还表明中药在抑制肿瘤细胞转化和转移方面具有积极效果。本文综述了中药在结肠癌预防中的最新研究进展，并展望了中药与现代医学结合的前景，以期推动中药在结肠癌防治中的应用和研究。
Abstract: Colorectal cancer (CRC), as a common malignant tumor in the digestive system, has a continuously rising incidence and mortality rate, becoming one of the significant challenges to global health. The high morbidity and mortality of colorectal cancer have prompted in-depth research on its prevention. Early prevention and intervention of colorectal cancer can not only effectively reduce the incidence but also improve the quality of life of patients. Traditional Chinese medicine (TCM) has shown significant potential with its unique therapeutic mechanisms. Chinese herbal medicine plays a role in preventing colorectal cancer through multiple mechanisms, including inhibiting precancerous lesions, regulating cell growth, promoting cell apoptosis, improving immune function, and reversing drug resistance. Additionally, studies have shown that Chinese herbal medicine has positive effects in inhibiting tumor cell transformation and metastasis. This article reviews the latest research progress of Chinese herbal medicine in the prevention of colorectal cancer and looks forward to the prospects of combining Chinese medicine with modern medicine, aiming to promote the application and research of Chinese herbal medicine in the prevention and control of colorectal cancer.
文章引用：徐督辉, 王威. 中药预防结肠癌的研究进展[J]. 中医学, 2025, 14(2): 539-546. https://doi.org/10.12677/tcm.2025.142080

参考文献

[1] 白姣姣, 阿丽亚∙依拉木, 阿布都艾则孜∙艾尔肯, 等. 中药复方及单体治疗结肠癌药效与机制研究进展[J]. 中国实验方剂学杂志, 2023, 29(4): 246-252.
[2] 梁欣宇, 林素琴, 王一斌, 等. 中药干预非酒精性脂肪性肝炎的机制研究进展[J]. 南京中医药大学学报, 2023, 39(4): 384-392.
[3] 廖韵诺, 赵凯丽, 郭宏伟. 中药网络药理学的研究应用与挑战[J]. 中草药, 2024, 55(12): 4204-4213.
[4] Clapper, M.L., Chang, W.L. and Cooper, H.S. (2020) Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention. Cancer Prevention Research, 13, 229-240. [Google Scholar] [CrossRef] [PubMed]
[5] Gee, J.M., Hara, H. and Johnson, I.T. (2002) Suppression of Intestinal Crypt Cell Proliferation and Aberrant Crypt Foci by Dietary Quercetin in Rats. Nutrition and Cancer, 43, 193-201. [Google Scholar] [CrossRef] [PubMed]
[6] Warren, C.A., Paulhill, K.J., Davidson, L.A., Lupton, J.R., Taddeo, S.S., Hong, M.Y., et al. (2009) Quercetin May Suppress Rat Aberrant Crypt Foci Formation by Suppressing Inflammatory Mediators That Influence Proliferation and Apoptosis. The Journal of Nutrition, 139, 101-105. [Google Scholar] [CrossRef] [PubMed]
[7] Tanaka, T., Kawabata, K., Honjo, S., Kohno, H., Murakami, M., Shimada, R., et al. (1999) Inhibition of Azoxymethane-Induced Aberrant Crypt Foci in Rats by Natural Compounds, Caffeine, Quercetin and Morin. Oncology Reports, 6, 1333-1373. [Google Scholar] [CrossRef] [PubMed]
[8] Volate, S.R., Davenport, D.M., Muga, S.J. and Wargovich, M.J. (2005) Modulation of Aberrant Crypt Foci and Apoptosis by Dietary Herbal Supplements (Quercetin, Curcumin, Silymarin, Ginseng and Rutin). Carcinogenesis, 26, 1450-1456. [Google Scholar] [CrossRef] [PubMed]
[9] Ashokkumar, P. and Sudhandiran, G. (2008) Protective Role of Luteolin on the Status of Lipid Peroxidation and Antioxidant Defense against Azoxymethane-Induced Experimental Colon Carcinogenesis. Biomedicine & Pharmacotherapy, 62, 590-597. [Google Scholar] [CrossRef] [PubMed]
[10] Ai, X., Qin, Y., Liu, H., Cui, Z., Li, M., Yang, J., et al. (2017) Apigenin Inhibits Colonic Inflammation and Tumorigenesis by Suppressing STAT3-NF-κB Signaling. Oncotarget, 8, 100216-100226. [Google Scholar] [CrossRef] [PubMed]
[11] 张伟, 邹孟龙, 徐寅, 等. 核受体PPARγ在溃疡性结肠炎中的作用及中医药干预研究进展[J]. 中国实验方剂学杂志, 2024, 30(8): 233-244.
[12] 王春霞, 葛俊李, 李芳, 等. 中药治疗溃疡性结肠炎作用及机制研究进展[J]. 中国实验方剂学杂志, 2023, 29(2): 270-282.
[13] 赵越, 王文萍, 李晓斌, 等. 小柴胡汤在恶性肿瘤全程管理中的应用研究进展[J]. 中国实验方剂学杂志, 2024, 30(12): 219-231.
[14] 申佳林, 赵小莹, 肖海娟. 四君子汤及其主要有效成分抗结直肠癌机制研究进展[J]. 中国实验方剂学杂志, 2024, 30(16): 240-252.
[15] 宋鑫, 张俊, 魏立强, 等. 黄芪多糖抑制结肠癌HT-29细胞生长作用研究[J]. 重庆医学, 2019, 48(17): 2899-2902.
[16] 李志林, 杜位良. 黄芪甲苷对结直肠癌CT26细胞的抗瘤作用初探[J]. 中国临床研究, 2019, 32(10): 1342-1345.
[17] Wang, S., Mou, J., Cui, L., Wang, X. and Zhang, Z. (2018) Astragaloside IV Inhibits Cell Proliferation of Colorectal Cancer Cell Lines through Down-Regulation of B7-H3. Biomedicine & Pharmacotherapy, 102, 1037-1044. [Google Scholar] [CrossRef] [PubMed]
[18] Tin, M.M.Y., Cho, C., Chan, K., James, A.E. and Ko, J.K.S. (2007) Astragalus Saponins Induce Growth Inhibition and Apoptosis in Human Colon Cancer Cells and Tumor Xenograft. Carcinogenesis, 28, 1347-1355. [Google Scholar] [CrossRef] [PubMed]
[19] 李华, 王捷虹. PI3K/Akt通路调控结直肠癌机制及中医药治疗研究进展[J]. 中国实验方剂学杂志, 2023, 29(13): 254-263.
[20] 韩非若, 李婷, 阿力亚∙麦麦提敏, 等. 桑椹化学成分与药理作用研究进展[J]. 中草药, 2024, 55(15): 5274-5285.
[21] 颜梦宇, 沈影, 刘芳媛, 等. 中药诱导卵巢癌凋亡相关基因机制研究进展[J]. 中国中西医结合杂志, 2023, 43(8): 1011-1018.
[22] Liu, K., Tian, T., Zheng, Y., Zhou, L., Dai, C., Wang, M., et al. (2019) Scutellarin Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Down‐Regulation of JAK2/STAT3 Pathway. Journal of Cellular and Molecular Medicine, 23, 3040-3044. [Google Scholar] [CrossRef] [PubMed]
[23] 刘洋, 王宇, 丛晶, 等. 中药调控NF-κB信号通路防治子宫内膜异位症作用机制的研究进展[J]. 上海中医药杂志, 2023, 57(8): 89-95.
[24] 张转红, 刘婷, 高飞云, 等. 中药抑制结肠癌血管生成的作用机制研究进展[J]. 中草药, 2023, 54(3): 948-955.
[25] 魏建昌, 曹杰, 杨平, 等. 藤黄酸对结直肠癌LOVO细胞增殖和血管生成素样蛋白4表达的影响[J]. 中国医药导报, 2015, 12(11): 4-6, 10.
[26] 李海英, 贺鹏, 李文姣, 等. 补阳还五汤化学成分、药理作用研究进展及质量标志物(Q-Marker)预测[J]. 中草药, 2024, 55(13): 4575-4587.
[27] 万莉. 藤黄酸对肿瘤血管生物系统的影响及其机制研究[D]: [博士学位论文]. 南京: 南京中医药大学, 2019.
[28] 杨培伟, 刘光伟, 赵文霞. 近十年半枝莲抗肿瘤作用机制研究概况[J]. 环球中医药, 2023, 16(5): 1051-1056.
[29] 王迪, 李钧, 侯兵乔, 等. 中药多糖对肿瘤微环境中免疫细胞调节作用研究进展[J]. 中草药, 2023, 54(13): 4346-4358.
[30] 李东东, 刘海燕, 宿抱玉, 等. 桑黄多糖对肿瘤微环境影响的研究[J]. 泰山医学院学报, 2020, 41(4): 318-320.
[31] 王峻, 周智东, 夏大静. 香菇多糖增强树突状细胞瘤苗的抗肿瘤作用及其机制研究[J]. 中国中西医结合杂志, 2007, 27(1): 60-64.
[32] Bamodu, O.A., Kuo, K., Wang, C., Huang, W., Wu, A.T.H., Tsai, J., et al. (2019) Astragalus Polysaccharides (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer. Nutrients, 11, Article 2264. [Google Scholar] [CrossRef] [PubMed]
[33] 陈艳平, 廖海锋, 王青, 等. 不同分子量的枸杞多糖组分对树突状细胞成熟的影响[J]. 中国免疫学杂志, 2021, 37(4): 385-388, 394.
[34] Zhou, Y., Zhang, J., Wang, K., Han, W., Wang, X., Gao, M., et al. (2020) Quercetin Overcomes Colon Cancer Cells Resistance to Chemotherapy by Inhibiting Solute Carrier Family 1, Member 5 Transporter. European Journal of Pharmacology, 881, Article ID: 173185. [Google Scholar] [CrossRef] [PubMed]
[35] Tian, Y., Li, Q., Liang, Y. and Hu, G. (2016) Enhanced Therapeutic Efficacy and Amelioration of Cisplatin-Induced Nephrotoxicity by Quercetin in 1,2-Dimethyl Hydrazine-Induced Colon Cancer in Rats. Indian Journal of Pharmacology, 48, 168-171. [Google Scholar] [CrossRef] [PubMed]
[36] Chen, X., Xu, H., Yu, X., Wang, X., Zhu, X. and Xu, X. (2019) Apigenin Inhibits in Vitro and in Vivo Tumorigenesis in Cisplatin-Resistant Colon Cancer Cells by Inducing Autophagy, Programmed Cell Death and Targeting m-TOR/PI3K/Akt Signalling Pathway. Journal of BUON, 24, 488-493.
[37] Lyu, X., Xu, X., Song, A., Guo, J., Zhang, Y. and Zhang, Y. (2019) Ginsenoside Rh1 Inhibits Colorectal Cancer Cell Migration and Invasion in Vitro and Tumor Growth in Vivo. Oncology Letters, 18, 4160-4166. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, H., Yi, J., Huang, H., Park, S., Kwon, W., Kim, E., et al. (2022) 20 (s)-Ginsenoside Rh2 Inhibits Colorectal Cancer Cell Growth by Suppressing the Axl Signaling Pathway in Vitro and in Vivo. Journal of Ginseng Research, 46, 396-407. [Google Scholar] [CrossRef] [PubMed]
[39] Liu, G., Liu, Y., Jiang, G. and Ren, W. (2018) The Reversal Effect of Ginsenoside Rh2 on Drug Resistance in Human Colorectal Carcinoma Cells and Its Mechanism. Human Cell, 31, 189-198. [Google Scholar] [CrossRef] [PubMed]
[40] Zhang, R., Wang, Z., Yu, Q., Shen, J., He, W., Zhou, D., et al. (2019) Atractylenolide II Reverses the Influence of Lncrna XIST/miR‐30a‐5p/ROR1 Axis on Chemo‐Resistance of Colorectal Cancer Cells. Journal of Cellular and Molecular Medicine, 23, 3151-3165. [Google Scholar] [CrossRef] [PubMed]
[41] 孙嘉玲, 韩克起, 方慧琪, 等. 中药治疗结肠癌药理机制研究进展[J]. 环球中医药, 2024, 17(2): 352-358.
[42] 徐振娜, 赵逸卿, 陈思宇, 等. 中西药联合用药的优势及风险分析[J]. 中草药, 2023, 54(2): 408-415.
[43] 李珊珊, 李玮婕, 王萍. 整合药理学在中医药现代研究的若干进展[J]. 中国实验方剂学杂志, 2024, 30(14): 270-278.